PPA
PFE icon

Parametric Portfolio Associates’s Pfizer PFE Stock Holding History

Parametric Portfolio Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.13B Buy
21,908,327
+217,479
+1% +$11.3M 0.6% 19
2021
Q4 		$1.28B Buy
21,690,848
+985,096
+5% +$48.8M 0.66% 18
2021
Q3 		$891M Sell
20,705,752
-6,418,194
-24% -$284M 0.51% 26
2021
Q2 		$1.06B Buy
27,123,946
+578,315
+2% +$22.5M 0.6% 20
2021
Q1 		$962M Buy
26,545,631
+2,089,297
+9% +$74.2M 0.55% 23
2020
Q4 		$900M Buy
24,456,334
+1,044,808
+4% +$38.3M 0.56% 23
2020
Q3 		$815M Buy
23,411,526
+1,798,060
+8% +$63M 0.59% 23
2020
Q2 		$671M Buy
21,613,466
+101,827
+0.5% +$3.46M 0.51% 27
2020
Q1 		$666M Sell
21,511,639
-536,181
-2% -$18.3M 0.61% 22
2019
Q4 		$820M Buy
22,047,820
+234,550
+1% +$8.35M 0.6% 22
2019
Q3 		$744M Sell
21,813,270
-1,071,482
-5% -$39M 0.6% 27
2019
Q2 		$941M Sell
22,884,752
-91,625
-0.4% -$3.64M 0.78% 13
2019
Q1 		$926M Buy
22,976,377
+368,394
+2% +$14.8M 0.8% 13
2018
Q4 		$936M Buy
22,607,983
+185,400
+0.8% +$7.7M 0.93% 11
2018
Q3 		$938M Sell
22,422,583
-70,882
-0.3% -$2.73M 0.82% 12
2018
Q2 		$774M Buy
22,493,465
+1,286,255
+6% +$44M 0.73% 14
2018
Q1 		$714M Buy
21,207,210
+680,317
+3% +$23.4M 0.7% 15
2017
Q4 		$705M Buy
20,526,893
+1,085,511
+6% +$37M 0.7% 14
2017
Q3 		$658M Buy
19,441,382
+1,119,549
+6% +$36M 0.72% 12
2017
Q2 		$584M Buy
18,321,833
+5,107,778
+39% +$161M 0.7% 12
2017
Q1 		$429M Sell
13,214,055
-4,582,542
-26% -$144M 0.66% 19
2016
Q4 		$548M Buy
17,796,597
+988,154
+6% +$30.2M 0.76% 14
2016
Q3 		$540M Buy
16,808,443
+922,588
+6% +$30.8M 0.81% 11
2016
Q2 		$531M Buy
15,885,855
+2,059,779
+15% +$65.7M 0.84% 11
2016
Q1 		$389M Sell
13,826,076
-144,842
-1% -$4.14M 0.63% 20
2015
Q4 		$428M Buy
13,970,918
+228,059
+2% +$7.17M 0.73% 17
2015
Q3 		$410M Buy
13,742,859
+1,570,804
+13% +$50.4M 0.8% 11
2015
Q2 		$387M Buy
12,172,055
+444,586
+4% +$14.5M 0.76% 11
2015
Q1 		$387M Buy
11,727,469
+725,482
+7% +$23.1M 0.78% 11
2014
Q4 		$325M Buy
11,001,987
+246,988
+2% +$7.08M 0.69% 14
2014
Q3 		$302M Sell
10,754,999
-438,047
-4% -$12.3M 0.67% 15
2014
Q2 		$315M Sell
11,193,046
-299,642
-3% -$8.54M 0.71% 12
2014
Q1 		$350M Sell
11,492,688
-165,771
-1% -$4.94M 0.83% 10
2013
Q4 		$339M Buy
11,658,459
+294,390
+3% +$8.57M 0.82% 11
2013
Q3 		$310M Sell
11,364,069
-522,695
-4% -$14.2M 0.84% 9
2013
Q2 		$316M Buy
+11,886,764
New +$328M 0.92% 11

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Parametric Portfolio Associates's PFE Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Pfizer (PFE) stake by 1% in Q1 2022, buying an estimated $11.3M and bringing the position to 21,908,327 shares worth $1.13B. The position accounts for 0.6% of the portfolio, ranked #19.

Parametric Portfolio Associates first reported a position in PFE in Q2 2013 and has held it in 36 quarters since. The position peaked at $1.28B in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Parametric Portfolio Associates held 21,908,327 shares of Pfizer worth $1.13B as of Q1 2022.
  • Parametric Portfolio Associates bought 217,479 Pfizer shares in Q1 2022, an estimated $11.3M.
  • Pfizer made up 0.6% of Parametric Portfolio Associates's portfolio in Q1 2022, its #19 holding.
  • Parametric Portfolio Associates first reported a position in Pfizer in Q2 2013 and has held it in 36 quarters since.
  • Parametric Portfolio Associates's Pfizer position peaked at $1.28B in Q4 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.